Changes in the intracellular levels of the essential micronutrient zinc have been implicated in multiple diseases including pancreatic cancer; however, the molecular mechanism is poorly understood. Here, we report a novel mechanism where increased zinc mediated by the zinc importer ZIP4 transcriptionally induces miR-373 in pancreatic cancer to promote tumour growth. Reporter, expression and chromatin immunoprecipitation assays demonstrate that ZIP4 activates the zinc-dependent transcription factor CREB and requires this transcription factor to increase miR-373 expression through the regulation of its promoter. miR-373 induction is necessary for efficient ZIP4-dependent enhancement of cell proliferation, invasion, and tumour growth. Further analysis of miR-373 in vivo oncogenic function reveals that it is mediated through its negative regulation of TP53INP1, LATS2 and CD44. These results define a novel ZIP4-CREB-miR-373 signalling axis promoting pancreatic cancer growth, providing mechanistic insights explaining in part how a zinc transporter functions in cancer cells and may have broader implications as inappropriate regulation of intracellular zinc levels plays an important role in many other diseases.
期刊论文详细信息
EMBO Molecular Medicine | |
A novel epigenetic CREB‐miR‐373 axis mediates ZIP4‐induced pancreatic cancer growth | |
Yuqing Zhang2  Jingxuan Yang1  Xiaobo Cui1  Yong Chen3  Vivian F. Zhu1  John P. Hagan1  Huamin Wang5  Xianjun Yu6  Sally E. Hodges2  Jing Fang8  Paul J. Chiao9  Craig D. Logsdon4  William E. Fisher2  F. Charles Brunicardi2  Changyi Chen2  Qizhi Yao2  Martin E. Fernandez-Zapico7  | |
[1] The Vivian L. Smith Department of Neurosurgery, the University of Texas Medical School at Houston, Houston, TX, USA;Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA;Division of Biostatistics, School of Public Health, the University of Texas Health Science Center at Houston, Houston, TX, USA;Department of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA;Department of Pathology, UT MD Anderson Cancer Center, Houston, TX, USA;Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN, USA;The Key Lab of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China;Department of Molecular and Cellular Oncology, UT MD Anderson Cancer Center, Houston, TX, USA | |
关键词: microRNA‐373; pancreatic cancer; zinc; ZIP4; | |
DOI : 10.1002/emmm.201302507 | |
来源: Wiley | |
【 摘 要 】
Abstract
【 授权许可】
CC BY
Copyright © 2013 EMBO Molecular Medicine
Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202107150009320ZK.pdf | 2550KB | download |